Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined Array Biopharma's (Nasdaq: ARRY) board of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE